StemVacs-V iPSC derived dendritic cell immunotherapy(Therapeutic Solutions International)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStemVacs-V iPSC derived dendritic cell immunotherapy(Therapeutic Solutions International)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionNatural killer cells stimulantsMacrophages stimulantsT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A